PACAP-27 vs Insulin Degludec

Head-to-head comparison of PACAP-27 (Pituitary Adenylate Cyclase-Activating Polypeptide-27) and Insulin Degludec (Insulin degludec (desB30, acylated ultra-long-acting insulin analog)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyPACAP-27Insulin Degludec
CategoryDiabetes & MetabolicDiabetes & Metabolic
Full NamePituitary Adenylate Cyclase-Activating Polypeptide-27Insulin degludec (desB30, acylated ultra-long-acting insulin analog)
Molecular Weight3158 Da6103.9 Da
Half-LifeminutesMore than 25 hours
Amino Acids2750
Typical DoseResearch-only: 0.1-1 nmol/kg0.1-0.2 U/kg once daily
RouteIntraperitoneal/SubcutaneousSubcutaneous
Purity≥98%≥98%
Studies Count2207000
Research StatusPre-clinicalApproved

PACAP-27 Benefits

  • anti-apoptotic signaling
  • insulin secretagogue effect
  • reduced ER stress
  • islet cytoprotection

Insulin Degludec Benefits

  • Ultra-long basal coverage
  • Lower day-to-day variability
  • Reduced nocturnal hypoglycemia
  • Flexible dosing time

PACAP-27 Dosing

0.1-1 nmol/kg in animal studies|10-100 nM in vitro|research-only intermittent dosing

Insulin Degludec Dosing

Inject SC once daily|Titrate to fasting glucose and HbA1c response|May be administered with flexible timing in adults

PACAP-27 Side Effects

  • flushing
  • hypotension at high exposure
  • headache

Insulin Degludec Side Effects

  • Hypoglycemia
  • Injection-site reactions
  • Weight gain

Research Overview

PACAP-27

PACAP-27 has been repeatedly shown to support beta-cell survival through cAMP/PKA and related pathways. In experimental models it mitigates cytokine damage, preserves insulin content, and helps maintain islet viability.

Insulin Degludec

Studies highlight prolonged action and lower glycemic variability compared with many other basal insulins. It is frequently used in research on ultra-long basal coverage and hypoglycemia reduction.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

PACAP-27 stacks with:

GLP-1 analogsDPP-4 inhibitorsdiet and exercise

Insulin Degludec stacks with:

Insulin LisproInsulin Aspart
neuropeptidebeta-cell protectioncAMP signalingultra-long-acting insulinbasal controllow variability